Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KC1086
- Development stage
- Phase 1
- Lead developer
- Beijing Konruns Pharmaceutical
- Modality
- Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
KC1086 is a **potent and highly selective small molecule inhibitor of lysine acetyltransferase 6A (KAT6A) and lysine acetyltransferase 6B (KAT6B)**, developed as an epigenetic therapeutic agent. It is intended for the treatment of advanced, recurrent, or metastatic solid tumors and is being evaluated in interventional clinical trials for safety, tolerability, pharmacokinetics, and preliminary efficacy. The drug is administered orally in cycles, and represents a novel structural class among KAT6 inhibitors, targeting critical epigenetic regulators implicated in oncogenesis[1][3][5][7][9].
- Brand names
- KC1086KC-1086KC 1086
- Other names
- KC1086KC-1086KC 1086
02
Targets
KAT6A (Lysine acetyltransferase 6A)KAT6B (Histone acetyltransferase KAT6B)
Beyond the preview
Go deeper on KC1086.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KC1086.